Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Hirai H | [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. | 2004 | Nippon Yakurigaku Zasshi | pmid:14695454 |
Uehara Y | [PGD(2)/L-PGDS system in hypertension and renal injury]. | 2004 | Nippon Yakurigaku Zasshi | pmid:14695455 |
Miwa Y et al. | Physiology and pharmacology of the prostaglandin J2 family. | 2004 | Nippon Yakurigaku Zasshi | pmid:14695456 |
Arai I | [Role of cutaneous prostaglandin D2 production on scratching dermatitis in mice]. | 2006 | Nippon Yakurigaku Zasshi | pmid:17167214 |
Tanaka H and Nagai H | [Inflammation-allergy and prostanoids. (2). The role of prostanoids in allergic inflammation]. | 2001 | Nippon Yakurigaku Zasshi | pmid:11338375 |
Tsukagoshi H and Kurosawa M | [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. | 1992 | Nippon Yakurigaku Zasshi | pmid:1559641 |
Urade Y | [New aspects on prostaglandin D synthases]. | 1997 | Nippon Yakurigaku Zasshi | pmid:9503406 |
Ushikubi F and Narumiya S | [The roles of the prostanoids played in the body]. | 2002 | Nippon Yakurigaku Zasshi | pmid:11979724 |
Sonoki H et al. | [Effects of 3,4-diaminopyridine on the contractions of guinea-pig tracheal smooth muscle induced by histamine and prostaglandin D2]. | 1988 | Nippon Yakurigaku Zasshi | pmid:3163668 |
Onoe H | [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. | 1998 | Nippon Yakurigaku Zasshi | pmid:10202759 |
Kikuchi Y et al. | [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma]. | 1990 | Nippon Sanka Fujinka Gakkai Zasshi | pmid:2313142 |
Kikuchi Y et al. | Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro. | 1987 | Nippon Sanka Fujinka Gakkai Zasshi | pmid:3479504 |
Masuko-Hongo K | [Role of prostaglandins in rheumatoid arthritis]. | 2005 | Nippon Rinsho | pmid:15799333 |
Makino S | [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. | 1985 | Nippon Rinsho | pmid:2989584 |
Uehara Y | [Prostaglandin D2]. | 1999 | Nippon Rinsho | pmid:10635955 |
Uehara Y | [Prostaglandin D2 and related substances]. | 2010 | Nippon Rinsho | pmid:20960740 |
Fukushima S et al. | [Pharmaceutical and pharmacological development of antitumor prostaglandins]. | 1998 | Nippon Rinsho | pmid:9549353 |
Uehara Y | [Prostaglandin D2]. | 2005 | Nippon Rinsho | pmid:16149440 |
Hayaishi O | [Prostaglandins and sleep]. | 1998 | Nippon Rinsho | pmid:9503823 |
Urade Y | [Gene engineering studies on sleep]. | 1998 | Nippon Rinsho | pmid:9503856 |
Uchizono K | [Studies of sleep inducing substance]. | 1984 | Nippon Rinsho | pmid:6384575 |
Urade Y | [Molecular mechanisms of insomnia]. | 2009 | Nippon Rinsho | pmid:19768929 |
Saito H | [Mast cells]. | 2005 | Nippon Rinsho | pmid:15861652 |
Fukushima M | [Prostaglandin J2--anti-tumor activity and mechanism of action]. | 1988 | Nippon Rinsho | pmid:3043050 |
Nagata N and Urade Y | [Endogenous sleep-promoting substance]. | 2012 | Nippon Rinsho | pmid:22844810 |
Wong P et al. | Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. | 1985 | Nippon Ketsueki Gakkai Zasshi | pmid:3890456 |
Kariya T et al. | Platelet abnormality with no response to PGD2 in a patient with metastatic pancreas carcinoma and myeloproliferative disorder. | 1987 | Nippon Ketsueki Gakkai Zasshi | pmid:3473883 |
Mezawa A | [Nasal response to chemical mediators in nasal allergy]. | 1988 | Nippon Jibiinkoka Gakkai Kaiho | pmid:3199260 |
Shiroma T et al. | [Production and metabolism of prostaglandin D2 by cultured chick retinal pigment epithelial cells]. | 1996 | Nippon Ganka Gakkai Zasshi | pmid:8741332 |
Goto H | [Quantitative determination of prostaglandin D2 in the rat gastric mucosa by high performance liquid chromatography]. | 1987 | Nihon Shokakibyo Gakkai Zasshi | pmid:3473244 |
Shimojima T et al. | [Effects of prostaglandins on superoxide production by human polymorphonuclear leukocytes]. | 1987 | Nihon Shishubyo Gakkai Kaishi | pmid:2851629 |
Fujitani Y et al. | [Sleep-promoting substances]. | 1998 | Nihon Ronen Igakkai Zasshi | pmid:10064966 |
Yamada K | [The effect of prostaglandin D2 on rat testicular testosterone levels]. | 1989 | Nihon Naibunpi Gakkai Zasshi | pmid:2591605 |
Suzuki H et al. | [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. | 1986 | Nihon Naibunpi Gakkai Zasshi | pmid:3465609 |
Kudo M et al. | [Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells]. | 1990 | Nihon Naibunpi Gakkai Zasshi | pmid:1962750 |
Hoshi A et al. | [Experimental study on the role of prostaglandin D2 in the pathogenesis of bronchial asthma]. | 1992 | Nihon Kyobu Shikkan Gakkai Zasshi | pmid:1507684 |
Fukuda T | [Trend in chemical mediator research in asthma and its application for asthma treatment]. | 2003 | Nihon Kokyuki Gakkai Zasshi | pmid:14531291 |
Ehara H | [An experimental study on antitumor effect of prostaglandin D2]. | 1989 | Nihon Geka Gakkai Zasshi | pmid:2796985 |
Nishimura G | [Antitumor activity and cell cycle effects of delta 12-PGJ2 in vivo]. | 1990 | Nihon Gan Chiryo Gakkai Shi | pmid:2351856 |
Sakai T | [Molecular cancer epidemiology--the present status and future possibilities]. | 1996 | Nihon Eiseigaku Zasshi | pmid:8720930 |
Liu H et al. | Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. | 2013 | Neurotoxicology | pmid:23973622 |
Toscano CD et al. | NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. | 2008 | Neurotoxicology | pmid:18834901 |
Shohami E et al. | Experimental closed head injury in rats: prostaglandin production in a noninjured zone. | 1988 | Neurosurgery | pmid:3164097 |
Hayaishi O and Urade Y | Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. | 2002 | Neuroscientist | pmid:11843094 |
Vesin MF et al. | Biosynthesis of prostaglandin D2 by motoneurons and dorsal horn microneurons: a biochemical and high resolution immunocytochemical study in chick spinal cord. | 1995 | Neuroscience | pmid:8596663 |
Liu M et al. | Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages. | 2007 | Neuroscience | pmid:17241746 |
Telleria-Diaz A et al. | Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation. | 2008 | Neuroscience | pmid:18678231 |
Zurich MG et al. | Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. | 2005 | Neuroscience | pmid:15994020 |
Pena-dos-Santos DR et al. | Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. | 2009 | Neuroscience | pmid:19647045 |
Horiguchi T et al. | Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. | 2006 | Neuroscience | pmid:16567054 |
Satoh S et al. | Promotion of sleep by prostaglandin D2 in rats made insomniac by pretreatment with para-chlorophenylalanine. | 1994 | Neurosci. Res. | pmid:7708292 |
Osaka T and Hayaishi O | Prostaglandin D2 modulates sleep-related and noradrenaline-induced activity of preoptic and basal forebrain neurons in the rat. | 1995 | Neurosci. Res. | pmid:8545074 |
Govoni S et al. | The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. | 2001 | Neurosci. Lett. | pmid:11311500 |
Leamy AW et al. | Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. | 2011 | Neurosci. Lett. | pmid:21855605 |
Nakae K et al. | Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. | 2005 | Neurosci. Lett. | pmid:16039053 |
Wu L et al. | Divergent effects of prostaglandin receptor signaling on neuronal survival. | 2007 | Neurosci. Lett. | pmid:17574754 |
Kitamura Y et al. | Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. | 1999 | Neurosci. Lett. | pmid:10203248 |
Marchini C et al. | Aspirin modulates LPS-induced nitric oxide release in rat glial cells. | 2005 Jun 10-17 | Neurosci. Lett. | pmid:15882795 |
Ott D et al. | Prostaglandin D2 modulates calcium signals induced by prostaglandin E2 in neurons of rat dorsal root ganglia. | 2015 | Neurosci. Lett. | pmid:25912777 |
Myeku N et al. | cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. | 2012 | Neurosci. Lett. | pmid:22982149 |
Inoué S et al. | Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. | 1984 | Neurosci. Lett. | pmid:6593603 |
Rohn TT et al. | 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. | 2001 | Neuroreport | pmid:11277593 |
Yoshida Y et al. | Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1/EP2. | 2000 | Neuroreport | pmid:10923657 |
Terao A et al. | Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. | 1998 | Neuroreport | pmid:9875706 |
Horváth B et al. | Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. | 2008 | Neuroreport | pmid:18815586 |
GarcÃa-Bueno B et al. | Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. | 2007 | Neuropsychopharmacology | pmid:17119541 |
Bate C et al. | Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. | 2006 | Neuropharmacology | pmid:16289250 |
Grill M et al. | Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. | 2006 | Neuropharmacology | pmid:16182321 |
Costello DA et al. | Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. | 2005 | Neuropharmacology | pmid:15993441 |
Morgenweck J et al. | Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. | 2010 | Neuropharmacology | pmid:19891980 |
Kaneko K et al. | Novel orexigenic pathway prostaglandin D2-NPY system--involvement in orally active orexigenic δ opioid peptide. | 2012 | Neuropeptides | pmid:23141054 |
Urade Y et al. | Sleep regulation in adenosine A2A receptor-deficient mice. | 2003 | Neurology | pmid:14663019 |
Dore-Duffy P et al. | Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. | 1991 | Neurology | pmid:1992386 |
Cho WH et al. | 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. | 2006 | Neurochem. Res. | pmid:17006759 |
Gotoh M et al. | Desensitization of prostaglandin F2 alpha receptor-mediated phosphoinositide hydrolysis in cultured rat astrocytes. | 1994 | Neurochem. Res. | pmid:8065525 |
Tsuji T et al. | Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. | 2009 | Neurochem. Res. | pmid:18946735 |
Li W et al. | Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. | 2008 | Neurochem. Res. | pmid:17763946 |
Naffah-Mazzacoratti MG et al. | Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. | 1995 | Neurochem. Int. | pmid:8574174 |
Flores JJ et al. | PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats. | 2016 | Neurobiol. Dis. | pmid:26739391 |
Ogburn KD et al. | Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. | 2006 | Neurobiol. Dis. | pmid:16406650 |
Liu H et al. | Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. | 2011 | Neurobiol. Dis. | pmid:20933087 |
Kootte AM et al. | The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. | 1983 | Neth J Med | pmid:6572798 |
Lu Y et al. | 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells. | 2013 | Nephron Exp. Nephrol. | pmid:23887394 |
Lee S et al. | Rosiglitazone ameliorates cisplatin-induced renal injury in mice. | 2006 | Nephrol. Dial. Transplant. | pmid:16728429 |
Li X et al. | Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. | 2007 | Nephrol. Dial. Transplant. | pmid:17255125 |
Panzer U et al. | 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. | 2008 | Nephrol. Dial. Transplant. | pmid:18596134 |
Kimura H et al. | A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. | 2008 | Nephrol. Dial. Transplant. | pmid:18367541 |
Prakash J et al. | Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. | 2009 | Neoplasia | pmid:20019843 |
Wang JP et al. | Anti-inflammatory and analgesic effects of magnolol. | 1992 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:1336574 |
Molderings GJ et al. | Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors. | 1998 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:9826066 |
Featherstone RL et al. | Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha. | 1990 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:2142256 |
Hsu MF et al. | Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils. | 2004 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:15083266 |
Ricote M et al. | The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. | 1998 | Nature | pmid:9422508 |
Jiang C et al. | PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. | 1998 | Nature | pmid:9422509 |
Rossi A et al. | Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. | 2000 | Nature | pmid:10638762 |
Luster AD and Tager AM | T-cell trafficking in asthma: lipid mediators grease the way. | 2004 | Nat. Rev. Immunol. | pmid:15343370 |
Wang C et al. | A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. | 2014 | Nat. Methods | pmid:24292485 |
Gilroy DW et al. | Inducible cyclooxygenase may have anti-inflammatory properties. | 1999 | Nat. Med. | pmid:10371510 |
Taketomi Y et al. | Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. | 2013 | Nat. Immunol. | pmid:23624557 |
Starkl P et al. | PLA2G3 promotes mast cell maturation and function. | 2013 | Nat. Immunol. | pmid:23685814 |